Table 2 Patient characteristics of SMC individuals from the ADNI study
From: Monte Carlo cross-validation for a study with binary outcome and limited sample size
N = 149 | \(\rho\) (p value) | |
|---|---|---|
Amyloid-\(\beta\) positivity (%) | 59 (35%) | |
APOE \(\varepsilon 4\) | 0.2670 (0.0004) | |
0 Copy | 109 (64.50%) | |
1 Copy | 54 (31.95%) | |
2 Copies | 6 (3.55%) | |
Age | 71.85 (6.11) | 0.2255 (0.0032) |
Edu | 16.83 (2.54) | 0.0136 (0.8606) |
Sex | 99 (58.58%) | \(-0.1370\) (0.0756) |
Hispanic | 6 (3.55%) | \(-0.0064\) (0.9347) |
Race | \(-0.0927\) (0.2306) | |
Whites | 152 (89.94%) | |
African American | 10 (5.92%) | |
Other | 7 (4.14%) | |
Marry status | 0.1435 (0.0627) | |
Married | 123 (72.78%) | |
Never married | 10 (5.92%) | |
Divorced | 18 (10.65 %) | |
Widowed | 18 (10.65%) | |
ADAS-cog13 | 10.40 (4.53) | 0.01239 (0.8734) |
MoCA | 25.93 (2.65) | \(-0.07430\) (0.3370) |
CDR-SB | 0.06 (0.17) | 0.02516 (0.7454) |
MMSE | 29.07 (1.17) | \(-0.05532\) (0.4750) |